166 related articles for article (PubMed ID: 8705267)
1. p53 expression in sweat gland tumors.
Biernat W; Woźniak L
Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of the myoepithelial cells in the benign and malignant sweat gland tumors.
Biemat W; Kordek R; Woźniak L
Pol J Pathol; 1996; 47(1):7-11. PubMed ID: 8705271
[TBL] [Abstract][Full Text] [Related]
3. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
5. DNA image cytometry in malignant and benign sweat gland tumours.
Vogelbruch M; Böcking A; Rütten A; Kapp A; Kiehl P
Br J Dermatol; 2000 Apr; 142(4):688-93. PubMed ID: 10792218
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in sweat gland carcinomas.
Biernat W; Peraud A; Wozniak L; Ohgaki H
Int J Cancer; 1998 May; 76(3):317-20. PubMed ID: 9579565
[TBL] [Abstract][Full Text] [Related]
7. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
Ansai S
Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
[TBL] [Abstract][Full Text] [Related]
9. TRPS1 Is Differentially Expressed in a Variety of Malignant and Benign Cutaneous Sweat Gland Neoplasms.
Zengin HB; Bui CM; Rybski K; Pukhalskaya T; Yildiz B; Smoller BR
Dermatopathology (Basel); 2023 Feb; 10(1):75-85. PubMed ID: 36810569
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
Piris A; Scopsi L; Clemente C; Cetti Serbelloni F; Mihm MC; Hoang MP
Am J Dermatopathol; 2010 Aug; 32(6):586-92. PubMed ID: 20534988
[TBL] [Abstract][Full Text] [Related]
12. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
[TBL] [Abstract][Full Text] [Related]
13. [Benign adnexal tumors of late occurrence in verrucoid-sebaceous nevus (Jadassohn). Apropos of 7 cases].
Bonvalet D; Barrandon Y; Foix C; Civatte J
Ann Dermatol Venereol; 1983; 110(4):337-42. PubMed ID: 6312866
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological Expression of p16INK4a is Commonly Present Both in Benign and Malignant Sweat Gland Neoplasias.
Tsujita J; Kaku Y; Ichiki T; Eto A; Maemura H; Otsuka A; Nakaie R; Kitagawa N; Morioka Y; Matsuda T; Yoshida M; Furue M
Fukuoka Igaku Zasshi; 2015 Dec; 106(12):323-9. PubMed ID: 27159948
[TBL] [Abstract][Full Text] [Related]
15. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers.
Sellheyer K
J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097
[TBL] [Abstract][Full Text] [Related]
16. Isoantigens A, B, H in normal skin and tumors of the epidermal appendages.
England DM; Solie B; Winkelmann RK
Arch Pathol Lab Med; 1979 Oct; 103(11):586-90. PubMed ID: 226027
[TBL] [Abstract][Full Text] [Related]
17. CD44 distribution in sweat gland tumors suggests it has different functional roles in the various cell types.
Fernández-Figueras MT; Puig L; Ariza A; Calatrava A; Fuente MJ; Ferrándiz C
Am J Dermatopathol; 1996 Oct; 18(5):483-9. PubMed ID: 8902095
[TBL] [Abstract][Full Text] [Related]
18. Spiradenocylindrocarcinoma: a malignant hybrid tumor.
Carlsten JR; Lewis MD; Saddler K; Reilly P; Pan T; Gnepp DR; Robinson-Bostom L
J Cutan Pathol; 2005 Feb; 32(2):166-71. PubMed ID: 15606677
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome.
Kazakov DV; Grossmann P; Spagnolo DV; Vanecek T; Vazmitel M; Kacerovska D; Zelger B; Calonje E; Michal M
Am J Dermatopathol; 2010 May; 32(3):215-221. PubMed ID: 20075707
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
